Ponatinib in Chronic Myeloid Leukaemia Refractory To Multiple Tyrosine Kinase Inhibitors: Data from a Tertiary Care Centre in India
Authors:
- Baalamurugan. K. TBTBaalamurugan. K. T
- Shouriyo GhoshSGShouriyo Ghosh
- Dibakar PodderDPDibakar Podder
- Sharthak GhoshSGSharthak Ghosh
- Manik GhoshMGManik Ghosh
- Arijit NagANArijit Nag
- Debranjani ChattopadhyayDCDebranjani Chattopadhyay
- Jeevan KumarJKJeevan Kumar
- Rizwan JavedRJRizwan Javed
- Saswata SahaSSSaswata Saha
- Asish RathARAsish Rath
- Sushant VinarkarSVSushant Vinarkar
- 22 October 2025
- journal article
- research article
- Published by Springer Nature in Indian Journal of Hematology and Blood Transfusion
- Vol. 42 (5) , 1-7
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Bosutinib versus imatinib for newly diagnosed chronic phase chronic myeloid leukemia: final results from the BFORE trialLeukemia, 2022
- Ponatinib dose-ranging study in chronic-phase chronic myeloid leukemia: a randomized, open-label phase 2 clinical trialBlood, 2021
- Poor tolerability to ponatinib in Indian CML patientsBlood Advances, 2020
- Side-effects profile and outcomes of ponatinib in the treatment of chronic myeloid leukemiaBlood Advances, 2020
- Arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real‐life practice are predicted by the Systematic Coronary Risk Evaluation (SCORE) chartHematological Oncology, 2019
- We do still transplant CML, don’t we?Hematology-American Society Hematology Education Program, 2018
- Ponatinib efficacy and safety in Philadelphia chromosome–positive leukemia: final 5-year results of the phase 2 PACE trialBlood, 2018
- Bosutinib is active in chronic phase chronic myeloid leukemia after imatinib and dasatinib and/or nilotinib therapy failureBlood, 2012
- Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid LeukemiaNew England Journal of Medicine, 2010
- Nilotinib versus Imatinib for Newly Diagnosed Chronic Myeloid LeukemiaNew England Journal of Medicine, 2010